Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth Cornetta

Showing results (71-80 of 88) with videos related to

Pageof 9
Sort By:
Human Gene Therapy|September 10, 2016
Lentivirus Mediated Correction of Artemis-Deficient Severe Combined ImmunodeficiencyDivya Punwani, Misako Kawahara, Jason Yu, et al.
Nature Communications|November 21, 2013
Platelet-targeted gene therapy with human factor VIII establishes haemostasis in dogs with haemophilia ALily M Du, Paquita Nurden, Alan T Nurden, et al.
Blood|March 14, 2007
Cytokine-independent growth and clonal expansion of a primary human CD8+ T-cell clone following retroviral transduction with the IL-15 geneCary Hsu, Stephanie A Jones, Cyrille J Cohen, et al.
Blood Advances|April 20, 2026
Clinical Outcomes of Lentiviral Vector Gene Therapy for Sickle Cell DiseaseChattip Prueksapraopong, Augustine Fernandes, Beatriz Campo Fernandez, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 26, 2015
[(18)F]FHBG PET/CT Imaging of CD34-TK75 Transduced Donor T Cells in Relapsed Allogeneic Stem Cell Transplant Patients: Safety and FeasibilityLinda G Eissenberg, Michael P Rettig, Julie K Ritchey, et al.
Molecular Therapy. Methods & Clinical Development|May 28, 2015
Preclinical safety and efficacy of an anti-HIV-1 lentiviral vector containing a short hairpin RNA to CCR5 and the C46 fusion inhibitorOrit Wolstein, Maureen Boyd, Michelle Millington, et al.
Molecular Therapy. Methods & Clinical Development|September 14, 2018
Screening Clinical Cell Products for Replication Competent Retrovirus: The National Gene Vector Biorepository ExperienceKenneth Cornetta, Lisa Duffy, Steven A Feldman, et al.
Science Translational Medicine|May 8, 2024
The translational gap for gene therapies in low- and middle-income countriesKevin W Doxzen, Jennifer E Adair, Yris Maria Fonseca Bazzo, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|November 22, 2013
Preclinical demonstration of lentiviral vector-mediated correction of immunological and metabolic abnormalities in models of adenosine deaminase deficiencyDenise A Carbonaro, Lin Zhang, Xiangyang Jin, et al.
Human Gene Therapy|March 23, 2013
Gene therapy for rare diseases: summary of a National Institutes of Health workshop, September 13, 2012Marina O'Reilly, Donald B Kohn, Jeffrey Bartlett, et al.
Pageof 9

Showing results (71-80 of 88) with videos related to

Sort By:
Pageof 9
Human Gene Therapy|September 10, 2016
Lentivirus Mediated Correction of Artemis-Deficient Severe Combined ImmunodeficiencyDivya Punwani, Misako Kawahara, Jason Yu, et al.
Nature Communications|November 21, 2013
Platelet-targeted gene therapy with human factor VIII establishes haemostasis in dogs with haemophilia ALily M Du, Paquita Nurden, Alan T Nurden, et al.
Blood|March 14, 2007
Cytokine-independent growth and clonal expansion of a primary human CD8+ T-cell clone following retroviral transduction with the IL-15 geneCary Hsu, Stephanie A Jones, Cyrille J Cohen, et al.
Blood Advances|April 20, 2026
Clinical Outcomes of Lentiviral Vector Gene Therapy for Sickle Cell DiseaseChattip Prueksapraopong, Augustine Fernandes, Beatriz Campo Fernandez, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 26, 2015
[(18)F]FHBG PET/CT Imaging of CD34-TK75 Transduced Donor T Cells in Relapsed Allogeneic Stem Cell Transplant Patients: Safety and FeasibilityLinda G Eissenberg, Michael P Rettig, Julie K Ritchey, et al.
Molecular Therapy. Methods & Clinical Development|May 28, 2015
Preclinical safety and efficacy of an anti-HIV-1 lentiviral vector containing a short hairpin RNA to CCR5 and the C46 fusion inhibitorOrit Wolstein, Maureen Boyd, Michelle Millington, et al.
Molecular Therapy. Methods & Clinical Development|September 14, 2018
Screening Clinical Cell Products for Replication Competent Retrovirus: The National Gene Vector Biorepository ExperienceKenneth Cornetta, Lisa Duffy, Steven A Feldman, et al.
Science Translational Medicine|May 8, 2024
The translational gap for gene therapies in low- and middle-income countriesKevin W Doxzen, Jennifer E Adair, Yris Maria Fonseca Bazzo, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|November 22, 2013
Preclinical demonstration of lentiviral vector-mediated correction of immunological and metabolic abnormalities in models of adenosine deaminase deficiencyDenise A Carbonaro, Lin Zhang, Xiangyang Jin, et al.
Human Gene Therapy|March 23, 2013
Gene therapy for rare diseases: summary of a National Institutes of Health workshop, September 13, 2012Marina O'Reilly, Donald B Kohn, Jeffrey Bartlett, et al.
Pageof 9